Propranolol Hydrochloride is used for treating hemangioma, including infantile hemangioma. It was first introduced by Wyeth Pharmaceuticals Llc in its drug Inderal on Approved Prior to Jan 1, 1982. Other drugs containing Propranolol Hydrochloride are Hemangeol, Inderal La, Innopran Xl, Propranolol Hydrochloride. 47 different companies have introduced drugs containing Propranolol Hydrochloride.

Propranolol Hydrochloride Patents

Given below is the list of patents protecting Propranolol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Hemangeol	US8338489	Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas	Oct 16, 2028	Pierre Fabre
Hemangeol	US8987262	Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas	Oct 16, 2028	Pierre Fabre
Innopran Xl	US6500454	Timed, sustained release systems for propranolol	Oct 04, 2021 (Expired)	Ani Pharms

Add above patents to watchlist

Propranolol Hydrochloride's Family Patents

Full family tree

Propranolol Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Propranolol Hydrochloride. The first generic version for Propranolol Hydrochloride was by Watson Laboratories Inc and was approved on Jul 30, 1985. And the latest generic version is by Lupin Ltd and was approved on Jan 12, 2024.

Given below is the list of companies who have filed for Propranolol Hydrochloride generic, along with the locations of their manufacturing plants worldwide.